瑞思迈

ResMed Director Farrell Peter C Sells 2,000 Shares at $251.47

ResMed's 15min chart shows Bollinger Bands expanding upward, bullish Marubozu pattern.

ResMed's 15min chart indicates MACD and KDJ Death Cross signals.

ResMed's 15min chart: Bollinger Bands Narrowing, KDJ Death Cross detected.

ResMed's 15min chart: MACD Death Cross, Bollinger Bands Narrowing Trigger

Catalyst<ul> <li>All five active analysts rate RMD as Buy, showing strong institutional confidence.</li> <li>Fundamental indicators such as strong cash reserves relative to market value and positive operating cash flow suggest solid financial health.</li></ul>Risk<ul> <li>Technical indicators show a weak trend with bearish signals dominant over the last 5 days, indicating caution is warranted.</li> <li>Net outflows are observed across all fund flow buckets, suggesting a lack of investor interest or concern.</li></ul>

Key Factors

ResMed Director Farrell Peter C. sold 2,000 shares at $251.47 on December 3, 2025.ResMed's 15-minute chart showed a bullish Marubozu pattern with expanding Bollinger Bands on December 4, 2025 at 12:30.

RMD News